Literature DB >> 18774771

Effective delivery of antisense peptide nucleic acid oligomers into cells by anthrax protective antigen.

Daniel G Wright1, Ying Zhang, John R Murphy.   

Abstract

Peptide nucleic acid (PNA) is highly stable and binds to complementary RNA and DNA with high affinity, but it resists cellular uptake, thereby limiting its bioavailability. We investigated whether protectiveantigen (PA, a non-toxic component of anthrax toxin) could transport antisense PNA oligomers into reporter cells that contain luciferase transgenes with mutant beta-globin IVS2 intronic inserts, which permit aberrant pre-mRNA splicing and impair luciferase expression. PNA oligomers antisense to mutant splice sites in these IVS2 inserts induced luciferase expression when effectively delivered into the cells. PNA 18-mers with C-terminal poly-lysine tails [PNA(Lys)(8)] demonstrated modest sequence-specific antisense activity by themselves at micromolar concentrations in luc-IVS2 reporter cell cultures. However, this activity was greatly amplified by PA. Antisense PNA(Lys)(8) with but not without PA also corrected the IVS2-654 beta-globin splice defect in cultured erythroid precursor cells from a patient with beta-thalassemia [genotype, IVS2-654(beta(0)/beta(E))], providing further evidence that anthrax PA can effectively transport antisense PNA oligomers into cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18774771      PMCID: PMC2581503          DOI: 10.1016/j.bbrc.2008.08.124

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

1.  Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal.

Authors:  G Cutrona; E M Carpaneto; M Ulivi; S Roncella; O Landt; M Ferrarini; L C Boffa
Journal:  Nat Biotechnol       Date:  2000-03       Impact factor: 54.908

Review 2.  Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future.

Authors:  A Ray; B Nordén
Journal:  FASEB J       Date:  2000-06       Impact factor: 5.191

Review 3.  Molecular mechanisms of action of antisense drugs.

Authors:  S T Crooke
Journal:  Biochim Biophys Acta       Date:  1999-12-10

Review 4.  Two problems in antisense biotechnology: in vitro delivery and the design of antisense experiments.

Authors:  C A Stein
Journal:  Biochim Biophys Acta       Date:  1999-12-10

Review 5.  Morpholino antisense oligomers: the case for an RNase H-independent structural type.

Authors:  J Summerton
Journal:  Biochim Biophys Acta       Date:  1999-12-10

6.  Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length.

Authors:  D F Doyle; D A Braasch; C G Simmons; B A Janowski; D R Corey
Journal:  Biochemistry       Date:  2001-01-09       Impact factor: 3.162

Review 7.  Selecting optimal antisense reagents.

Authors:  M Sohail; E M Southern
Journal:  Adv Drug Deliv Rev       Date:  2000-10-31       Impact factor: 15.470

Review 8.  Antisense therapy in oncology: new hope for an old idea?

Authors:  I Tamm; B Dörken; G Hartmann
Journal:  Lancet       Date:  2001-08-11       Impact factor: 79.321

9.  Restoration of hemoglobin A synthesis in erythroid cells from peripheral blood of thalassemic patients.

Authors:  G Lacerra; H Sierakowska; C Carestia; S Fucharoen; J Summerton; D Weller; R Kole
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

Review 10.  The versatility of oligonucleotides as potential therapeutics.

Authors:  Fritz Eckstein
Journal:  Expert Opin Biol Ther       Date:  2007-07       Impact factor: 4.388

View more
  3 in total

1.  Targeting Cancer Gene Dependencies with Anthrax-Mediated Delivery of Peptide Nucleic Acids.

Authors:  Zeyu Lu; Brenton R Paolella; Nicholas L Truex; Alexander R Loftis; Xiaoli Liao; Amy E Rabideau; Meredith S Brown; John Busanovich; Rameen Beroukhim; Bradley L Pentelute
Journal:  ACS Chem Biol       Date:  2020-05-11       Impact factor: 5.100

2.  A Dominant Negative Antisense Approach Targeting β-Catenin.

Authors:  Matthias Vonbrüll; Elisabeth Riegel; Christian Halter; Michaela Aigner; Holger Bock; Birgit Werner; Thomas Lindhorst; Thomas Czerny
Journal:  Mol Biotechnol       Date:  2018-05       Impact factor: 2.695

3.  Generation and Characterization of a Transgenic Mouse Carrying a Functional Human β -Globin Gene with the IVSI-6 Thalassemia Mutation.

Authors:  Giulia Breveglieri; Irene Mancini; Nicoletta Bianchi; Ilaria Lampronti; Francesca Salvatori; Enrica Fabbri; Cristina Zuccato; Lucia C Cosenza; Giulia Montagner; Monica Borgatti; Fiorella Altruda; Sharmila Fagoonee; Gianni Carandina; Michele Rubini; Vincenzo Aiello; Laura Breda; Stefano Rivella; Roberto Gambari; Alessia Finotti
Journal:  Biomed Res Int       Date:  2015-05-04       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.